Elvitegravir/Cobicistat/Emtricitabine/TAF
$3,619
Avg Cost per Claim
Generic Available
Medicare Part D spent $2345M on Genvoya across 648,000 claims.
View full report →Source: CMS Medicare Part D Spending, 2026.
Data from DrugPrice
Medicare Part D spent $2345M on Genvoya across 648,000 claims.
View full report →Source: CMS Medicare Part D Spending, 2026.